[1]
Cechim, G. et al. 2021. Increased systemic IL-6 levels indicate inflammation as a determinant component in renal cell carcinoma development. Clinical and Biomedical Research. 41, 3 (out. 2021). DOI:https://doi.org/10.22491/2357-9730.108350.